Repeated sauna treatment, known as Waon therapy, has been shown to improve cardiac
function as well as exercise tolerance in patients with chronic heart failure. However,
the underlying mechanisms of this therapy regarding these improvements remain to be
elucidated. Forty-one patients with chronic heart failure (mean age 68.3 ± 13.5 years
old) underwent Waon therapy 5 times a week for 3 weeks. Before and after treatment,
a number of assessments were performed in all subjects: 6-minute walk test, echocardiography,
determination of neurohumoral factors and number of circulating CD34+ cells, and a flow-mediated dilation (FMD) test of endothelial function. Cardiopulmonary
exercise testing was also performed in 20 patients. Waon therapy increased the left
ventricular ejection fraction (from 30.4 ± 12.6% to 32.5% ± 12.8%, p = 0.023) and
reduced plasma levels of norepinephrine (from 400 ± 258 to 300 ± 187 pg/ml, p = 0.015)
and brain natriuretic peptide (from 550 ± 510 to 416 ± 431 pg/ml, p = 0.035). Waon
therapy increased the 6-minute walk distance (from 337 ± 120 to 379 ± 126 m, p <0.001)
in association with an improvement in FMD (from 3.5 ± 2.3% to 5.5% ± 2.7%, p <0.001)
and an increase in the number of circulating CD34+ cells (p = 0.025). Changes in 6-minute walk distance were correlated positively with
those in the left ventricular ejection fraction and FMD and negatively with those
in plasma levels of norepinephrine and brain natriuretic peptide levels. A multivariate
analysis revealed that an increase in FMD was the only independent determinant of
6-minute walk distance improvement. Finally, Waon therapy significantly increased
peak Vo2, and this increase was also correlated with changes in FMD. In conclusion, repeated
sauna therapy in patients with chronic heart failure improves exercise tolerance in
association with improvement in endothelial function.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Waon therapy: soothing warmth therapy.J Cardiol. 2007; 49: 301-304
- Acute hemodynamic improvement by thermal vasodilation in congestive heart failure.Circulation. 1995; 91: 2582-2590
- Repeated thermal therapy treatment improves vascular endothelial and cardiac function in patients with chronic heart failure.J Am Coll Cardiol. 2002; 39: 754-759
- Beneficial effects of Waon therapy on patients with chronic heart failure: results of a prospective multicenter study.J Cardiol. 2008; 52: 79-85
- Waon therapy improves the prognosis of patients with chronic heart failure.J Cardiol. 2009; 53: 214-218
- Waon therapy improves peripheral arterial disease.J Am Coll Cardiol. 2007; 50: 2169-2171
- Repeated thermal therapy up-regulates endothelial nitric oxide synthase and augments angiogenesis in a mouse model of hindlimb ischemia.Circ J. 2006; 70: 463-470
- Endothelium-dependent vasodilation is attenuated in patients with heart failure.Circulation. 1991; 84: 1589-1596
- Endothelial function in chronic congestive heart failure.Am J Cardiol. 1992; 69: 1596-1601
- Limb blood flow during exercise is dependent on nitric oxide.Circulation. 1998; 98: 369-374
- Waon therapy for cardiovascular disease: innovative therapy for the 21st century.Circ J. 2010; 74: 617-621
- Safety and efficacy of repeated sauna bathing in patients with chronic systolic heart failure: a preliminary report.J Card Fail. 2005; 11: 432-436
- Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death.Eur Heart J. 2005; 26: 65-69
- Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure.Circulation. 1998; 98: 2709-2715
- Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina.Circulation. 2010; 122: 1612-1620
- Physical training improves endothelial function in patients with chronic heart failure.Circulation. 1996; 93: 210-214
- Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease.J Am Coll Cardiol. 2001; 38: 1843-1849
- Repeated thermal therapy improves impaired vascular endothelial function in patients with coronary risk factors.J Am Coll Cardiol. 2001; 38: 1083-1088
- Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.N Engl J Med. 2003; 348: 593-600
- Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure.Heart. 2007; 93: 1046-1050
- Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease.Circulation. 2001; 103: 2885-2890
- Repeated sauna therapy attenuates ventricular remodeling after myocardial infarction in rats by increasing coronary vascularity of noninfarcted myocardium.Am J Physiol Heart Circ Physiol. 2011; 301: H548-H554
- VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells.EMBO J. 1999; 18: 3964-3972
- Correlation between CD34+ and exercise capacity, functional class, quality of life and norepinephrine in heart failure patients.Cardiol J. 2009; 16: 426-431
- Waon therapy mobilizes CD34+ cells and improves peripheral arterial disease.J Cardiol. 2010; 56: 361-366
- Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review.Eur Heart J. 2005; 26: 778-793
Article info
Publication history
Published online: September 26, 2011
Accepted:
August 4,
2011
Received in revised form:
August 4,
2011
Received:
July 1,
2011
Identification
Copyright
© 2012 Elsevier Inc. Published by Elsevier Inc. All rights reserved.